Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   High-Affinity Interactions of the nSH3/cSH3 Domains of Grb2 with the C-Terminal Proline-Rich Domain of SOS1
  2. Liao,Tsung-Jen; Jang,Hyunbum; Nussinov,Ruth; Fushman, David
  3. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2020, Feb 19; 142: 3401-3411.
  1. 2.   Stem-Cell-Based Tumorigenesis in Adult Drosophila
  2. Hou, Steven; Singh, Shree Ram; Pick, L
  3. FLY MODELS OF HUMAN DISEASES (Book Series: Current Topics in Developmental Biology). 2017; 121 : 311-337.
  1. 3.   LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?
  2. Orr, S. J.; McVicar, D. W.
  3. Journal of Leukocyte Biology. 2011, Jan; 89(1): 11-19.
  1. 4.   TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release
  2. Smrz, D.; Iwaki, S.; McVicar, D. W.; Metcalfe, D. D.; Gilfillan, A. M.
  3. European Journal of Immunology. 2010, Dec; 40(12): 3557-3569.
  1. 5.   Opposing Effects of a Tyrosine-Based Sorting Motif and a PDZ-Binding Motif Regulate Human T-Lymphotropic Virus Type 1 Envelope Trafficking
  2. Ilinskaya, A.; Heidecker, G.; Derse, D.
  3. Journal of Virology. 2010, Jul; 84(14): 6995-7004.
  1. 6.   Identification of Shc Src Homology 2 Domain-Binding Peptoid-Peptide Hybrids
  2. Choi, W. J.; Kim, S. E.; Stephen, A. G.; Weidlich, I.; Giubellino, A.; Liu, F.; Worthy, K. M.; Bindu, L.; Fivash, M. J.; Nicklaus, M. C.; Bottaro, D. P.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2009 52(6): 1612-1618.
  1. 7.   The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis
  2. Roberts, Z. J.; Goutagny, N.; Perera, P. Y.; Kato, H.; Kumar, H.; Kawai, T.; Akira, S.; Savan, R.; van Echo, D.; Fitzgerald, K. A.; Young, H. A.; Ching, L. M.; Vogel, S. N.
  3. Journal of Experimental Medicine. 2007, Jul; 204(7): 1559-1569.
  1. 8.   Grb10 and active Raf-1 kinase promote bad-dependent cell survival
  2. Kebache, S.; Ash, J.; Annis, M. G.; Hagan, J.; Huber, M.; Hassard, J.; Stewart, C. L.; Whiteway, M.; Nantel, A.
  3. Journal of Biological Chemistry. 2007, Jul; 282(30): 21873-21883.
  1. 9.   Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain
  2. Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. L.; Perch, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.
  3. Journal of Molecular Recognition. 2007, Jul-Aug; 20(4): 245-252.
  1. 10.   Inhibition of HIV-1 replication by amphotericin B methyl ester - Selection for resistant variants
  2. Waheed, A. A.; Ablan, S. D.; Mankowski, M. K.; Cummins, J. E.; Ptak, R. G.; Schaffner, C. P.; Freed, E. O.
  3. Journal of Biological Chemistry. 2006, Sep; 281(39): 28699-28711.
  1. 11.   Immunogenicity testing of a novel engineered HIV-1 envelope Gp140 DNA vaccine construct
  2. Kumar, S.; Yan, J.; Muthumani, K.; Ramanathan, M. P.; Yoon, H.; Pavlakis, G. N.; Felber, B. K.; Sidhu, M.; Boyer, J. D.; Weiner, D. B.
  3. DNA and Cell Biology. 2006, Jul; 25(7): 383-392.
  1. 12.   Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes
  2. Valencia, J. C.; Watabe, H.; Chi, A.; Rouzaud, F.; Chen, K. G.; Vieira, W. D.; Takahashi, K.; Yamaguchi, Y.; Berens, W.; Nagashima, K.; Shabanowitz, J.; Hunt, D. F.; Appella, E.; Hearing, V. J.
  3. Journal of Cell Science. 2006, Mar; 119(6): 1080-1091.
  1. 13.   Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion
  2. Yang, H. S.; Matthews, C. P.; Clair, T.; Wang, Q.; Baker, A. R.; Li, C. C. H.; Tan, T. H.; Colburn, N. H.
  3. Molecular and Cellular Biology. 2006, Feb; 26(4): 1297-1306.
  1. 14.   Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain
  2. Phan, J.; Shi, Z. D.; Burke, T. R.; Waugh, D. S.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 104-115.
  1. 15.   Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail
  2. Wyss, S.; Dimitrov, A. S.; Baribaud, F.; Edwards, T. G.; Blumenthal, R.; Hoxie, J. A.
  3. Journal of Virology. 2005, OCT; 79(19): 12231-12241.
  1. 16.   Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus
  2. Yuste, E.; Johnson, W.; Pavlakis, G. N.; Desrosiers, R. C.
  3. Journal of Virology. 2005, OCT; 79(19): 12455-12463.
  1. 17.   Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
  2. Youn, H. S.; Lee, J. Y.; Fitzgerald, K. A.; Young, H. A.; Akira, S.; Hwang, D. H.
  3. Journal of Immunology. 2005, SEP 1; 175(5): 3339-3346.
  1. 18.   Cutting edge: Expression of IL-1 receptor-associated kinase-4 (IRAK-4) proteins with mutations identified in a patient with recurrent bacterial infections alters normal IRAK-4 interaction with components of the IL-1 receptor complex
  2. Medvedev, A. E.; Thomas, K.; Awomoyi, A.; Kuhns, D. B.; Gallin, J. I.; Li, X. X.; Vogel, S. N.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 6587-6591.
  1. 19.   Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain
  2. Long, Y. Q.; Guo, R. B.; Luo, J. H.; Yang, D. J.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2003 310(2): 334-340.
  1. 20.   Cbl-3-deficient mice exhibit normal epithelial development
  2. Griffiths, E. K.; Sanchez, O.; Mill, P.; Krawczyk, C.; Hojilla, C. V.; Rubin, E.; Nau, M. M.; Khokha, R.; Lipkowitz, S.; Hui, C. C.; Penninger, J. M.
  3. Molecular and Cellular Biology. 2003 23(21): 7708-7718.
  1. 21.   Global optimization of conformational constraint on non- phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain
  2. Long, Y. Q.; Lung, F. D. T.; Roller, P. P.
  3. Bioorganic & Medicinal Chemistry. 2003 11(18): 3929-3936.
  1. 22.   The four distal tyrosines are required for LAT-dependent signaling in Fc epsilon RI-mediated mast cell activation
  2. Saitoh, S.; Odom, S.; Gomez, G.; Sommers, C. L.; Young, H. A.; Rivera, J.; Samelson, L. E.
  3. Journal of Experimental Medicine. 2003 198(5): 831-843.
  1. 23.   Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6
  2. Zhang, Q.; Zhao, B. H.; Li, W.; Oiso, N.; Novak, E. K.; Rusiniak, M. E.; Gautam, R.; Chintala, S.; O'Brien, E. P.; Zhang, Y.; Roe, B. A.; Elliott, R. W.; Eicher, E. M.; Liang, P.; Kratz, C.; Legius, E.; Spritz, R. A.; O'Sullivan, T. N.; Copeland, N. G.; Jenkins, N. A.; Swank, R. T.
  3. Nature Genetics. 2003 33(2): 145-153.
  1. 24.   Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance
  2. Lung, F. D. T.; Tsai, J. Y.; Wei, S. Y.; Cheng, J. W.; Chen, C.; Li, P.; Roller, P. P.
  3. Journal of Peptide Research. 2002 60(3): 143-149.
  1. 25.   c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation
  2. Naramura, M.; Jang, I. K.; Kole, H.; Huang, F.; Haines, D.; Gu, H.
  3. Nature Immunology. 2002 3(12): 1192-1199.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel